DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...
Medtech leaders with varying degrees of experience have offered a range of advice in terms of leadership at the helm of a ...
Fintel reports that on October 7, 2025, Citigroup maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation.
On September 19, William Blair analyst Brandon Vazquez maintained their bullish stance on the company’s stock, giving a “Buy” rating. The analyst’s rating is backed by a combination of factors ...
Digital Photography Review on MSN

How to use my camera's light meter

Dialing in your aperture, shutter speed and ISO doesn't have to be a game of guesswork when using manual mode. If you're ...